Quality Investor

Helios Technologies, Inc.

Rank #367Capital Return

HLIO · NYSE · Industrials

Helios Technologies, Inc. (HLIO) — Rank #367 by gross profitability (GP/assets 0.18) · ROE 5.1% · Piotroski F-Score 9 / 9.

As-of 2026-09-28 · CIK 0001024795 · all metrics point-in-time as of the filing date.

About

Helios Technologies, Inc., together with its subsidiaries, provides engineered motion control and electronic controls technology solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific.

Show more

It operates through two segments; Hydraulics and Electronics. The Hydraulics segment designs and manufactures hydraulic motion control and fluid conveyance technology products, including cartridge valves, manifolds, and quick release couplings, as well as engineers complete hydraulic system solutions. This segment sells its products under the Sun Hydraulics, Faster, NEM, Taimi, Daman, and Schultes brands. The Electronics segment designs and manufactures customized electronic controls systems, displays, wire harnesses, and software solutions. This segment sells its products under Enovation Controls, Murphy, Zero Off, HCT, Balboa Water Group, i3PD and Cygnus Reach and Joyonway brands. It markets and sells hydraulic products and engineered solutions through value-added distributors, as well as directly to original equipment manufacturers (OEMs); and electronic products to OEMs, distributors, and system integrators. It serves construction, material handling, agriculture, industrial, mobile, energy, recreational vehicles, marine, aerospace, and health and wellness sectors. The company was formerly known as Sun Hydraulics Corporation and changed its name to Helios Technologies, Inc. in June 2019. Helios Technologies, Inc.

was incorporated in 1970 and is headquartered in Sarasota, Florida.

Industry
Specialty Industrial Machinery
Sector
Industrials
State
FL
Filer Category
Large accelerated filer
Fiscal Year End
December 30

Company Snapshot

P/E and reverse DCF are the primary valuation lenses at this stage.

Market Cap

—

P/E (annual)

—

P/S (annual)

—

P/B

—

P/OCF (annual)

—

Shareholder Yield

—

Employees

2,300

Industry

Specialty Industrial Machinery

Exchange

NYSE

Signal Flags

2 green1 red
Revenue growth acceleratingGrowth rate increasing year over year
Sequential beat (rev + EPS)Both revenue and EPS exceeded prior quarter — 1-quarter streak
Operating margin decliningOperating margin lower than prior year

Quality Profile

Profitability

1/1 pass
GP / assets
0.18
Return on equity
5.1%
Gross margin trend
PASS

Safety

1/1 pass
Balance-sheet safety
PASS
Debt / equity
0.60
Current ratio
2.74×
Net cash
-$158.10M

Cash Flow

3/3 pass
Positive FCF
PASS
Cash-backed earnings
PASS
Accruals healthy
PASS
SBC / revenue
0.6%

Growth

2/2 pass
Revenue growth
4.1%
Piotroski F-Score
9 / 9
Share dilution
0.0%

Terry Smith quality gate

Passes 1/5 Terry Smith thresholds

1 of 5 threshold not computable from filed data.

FCF yield, shareholder yield, and buyback activity are the primary reads at this stage.

Profitability

Gross profitability (GP / assets)

0.18

Primary signal (Novy-Marx).

5th of 5 SIC 3490 peers

Return on equity

5.1%

Gross margin

32.3%

5th of 5 SIC 3490 peers

Revenue growth (YoY)

4.1%

Gross margin improving

Margin trend vs prior year.

PASS

Operating Leverage

2022202320242026
Revenue vs COGS
Revenue vs OpEx
Op. Income vs Revenue

Growth

Revenue CAGR (3Y)

-1.8%

Revenue CAGR (5Y)

9.9%

Earnings CAGR (3Y)

-21.1%

FCF CAGR (3Y)

9.9%

Anti-fragile safety

Balance-sheet safety

Composite anti-fragile check.

PASS

Debt / equity

0.60

2nd of 5 SIC 3490 peers (best = lowest)

Current ratio

2.74×

3rd of 5 SIC 3490 peers

Quick ratio

1.30×

Net cash

-$158.10M

Cash & equivalents minus total debt.

Recession resistance

Revenue through recessions

Worst single-year YoY revenue decline, 17 years of history

No recession-window coverage
2008-2009 (GFC)
N/AN/A
2020 (COVID)
N/AN/A
Worst year on record(any fiscal year, not recession-limited)
-11.8%Significant decline

Cash-flow health

Free cash flow

$103.60M

Operating cash flow minus capex.

Positive free cash flow

PASS

FCF / net income

1.14

Cash-backing of earnings.

FCF/NI divergence

Unfavorable divergence (yellow flag).

PASS

Accruals healthy

Cash-backed earnings.

PASS

SBC / revenue

0.6%

Stock-based comp intensity.

Dividend safety

Composite score

3.5 / 5

Good
Payout ratio
24.8%5/5 Strong
FCF coverage
8.63×5/5 Strong
Dividend growth streak
4 yr2/5 Fair
Balance-sheet health
D/E 0.60 · IC N/A2/5 Fair

Piotroski F-Score

F-Score

9 / 9

Fundamental-strength score (0-9).

Lifecycle Phase History

20212026
Decline
Hypergrowth
Value
Capital Return